Deutsche Bank’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$195K Buy
7,358
+447
+6% +$11.8K ﹤0.01% 2975
2025
Q1
$167K Buy
6,911
+484
+8% +$11.7K ﹤0.01% 3009
2024
Q4
$259K Sell
6,427
-15,284
-70% -$615K ﹤0.01% 2947
2024
Q3
$1.37M Sell
21,711
-102,983
-83% -$6.52M ﹤0.01% 1938
2024
Q2
$6.61M Sell
124,694
-46,650
-27% -$2.47M ﹤0.01% 1135
2024
Q1
$14.1M Sell
171,344
-688,347
-80% -$56.4M 0.01% 923
2023
Q4
$16M Buy
859,691
+541,403
+170% +$10.1M 0.01% 848
2023
Q3
$3.52M Buy
318,288
+37,549
+13% +$416K ﹤0.01% 1138
2023
Q2
$4.55M Buy
280,739
+41,538
+17% +$673K ﹤0.01% 1272
2023
Q1
$3.98M Sell
239,201
-1,466
-0.6% -$24.4K ﹤0.01% 1328
2022
Q4
$2.26M Hold
240,667
﹤0.01% 1586
2022
Q3
$655K Hold
240,667
﹤0.01% 2224
2022
Q2
$696K Sell
240,667
-37,130
-13% -$107K ﹤0.01% 2391
2022
Q1
$833K Sell
277,797
-4,418
-2% -$13.2K ﹤0.01% 2454
2021
Q4
$1.3M Buy
282,215
+1,261
+0.4% +$5.8K ﹤0.01% 2264
2021
Q3
$1.76M Sell
280,954
-2,685
-0.9% -$16.9K ﹤0.01% 2185
2021
Q2
$1.7M Sell
283,639
-1,502
-0.5% -$9K ﹤0.01% 2377
2021
Q1
$1.8M Buy
285,141
+61,194
+27% +$387K ﹤0.01% 2235
2020
Q4
$1.26M Buy
223,947
+12,577
+6% +$70.8K ﹤0.01% 2281
2020
Q3
$1.23M Sell
211,370
-1,247
-0.6% -$7.26K ﹤0.01% 2054
2020
Q2
$1.53M Buy
212,617
+44,105
+26% +$318K ﹤0.01% 1945
2020
Q1
$788K Sell
168,512
-1,392
-0.8% -$6.51K ﹤0.01% 2220
2019
Q4
$1.36M Buy
169,904
+4,797
+3% +$38.4K ﹤0.01% 2194
2019
Q3
$1.14M Sell
165,107
-3,098
-2% -$21.3K ﹤0.01% 2220
2019
Q2
$1.39M Sell
168,205
-3,552
-2% -$29.4K ﹤0.01% 2602
2019
Q1
$1.71M Sell
171,757
-657
-0.4% -$6.52K ﹤0.01% 2608
2018
Q4
$1.32M Sell
172,414
-416,663
-71% -$3.19M ﹤0.01% 2671
2018
Q3
$10.3M Buy
589,077
+372,890
+172% +$6.5M 0.01% 1606
2018
Q2
$2.05M Buy
216,187
+215,512
+31,928% +$2.05M ﹤0.01% 2915
2018
Q1
$2K Sell
675
-1,625
-71% -$4.82K ﹤0.01% 4793
2017
Q4
$9K Buy
+2,300
New +$9K ﹤0.01% 4311